Testing is increasingly performed to identify clinically relevant germline and/or somatic variants in BRCA1/2 in four cancer entities (Table 2) and to detect microsatellite instable tumors, possibly related to Lynch syndrome, which requires further workup. This evidence concerns the gene BRCA1 and Lynch syndrome.